विधियों की तुलना करें
चुनी हुई विधियों की आमने-सामने समीक्षा करें; भिन्नता वाली पंक्तियाँ रेखांकित हैं।
| मधुमेह लक्षण प्रश्नावली (Diabetes Symptom Checklist)× | क्लार्क हाइपोग्लाइसीमिया जागरूकता प्रश्नावली× | |
|---|---|---|
| क्षेत्र | अंतःस्रावी विज्ञान | अंतःस्रावी विज्ञान |
| परिवार | Process / pipeline | Process / pipeline |
| उद्भव वर्ष≠ | 1994 | 1995 |
| प्रवर्तक≠ | Peta Grootenhuis, Frans Snoek, Rolf Heine, Lex Bouter | William L. Clarke, Don J. Cox, Lois A. Gonder-Frederick |
| प्रकार≠ | Patient self-report symptom checklist | Patient self-report questionnaire |
| मौलिक स्रोत≠ | Grootenhuis, P. A., Snoek, F. J., Heine, R. J., & Bouter, L. M. (1994). Development of a type 2 diabetes symptom checklist: A measure of symptom severity. Diabet Med, 11(3), 253-261. DOI ↗ | Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995). Reduced awareness of hypoglycemia in adults with IDDM: A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care, 18(6), 517-522. DOI ↗ |
| उपनाम≠ | DSC-34 | HAQ, Clarke HAQ, Hypoglycemia Awareness Scale |
| संबंधित | 3 | 3 |
| सारांश≠ | The Diabetes Symptom Checklist is a 34-item patient-reported outcome measure assessing the frequency and burden of symptoms directly related to diabetes and its complications. Developed by Grootenhuis and colleagues in 1994, it captures eight symptom dimensions including hyperglycemic symptoms, hypoglycemic symptoms, fatigue, polyuria, neuropathic pain, and psychological distress. The instrument is used to quantify symptom experience and treatment response across diverse diabetes populations. | The Clarke Hypoglycemia Awareness Questionnaire is an 8-item instrument designed to identify patients with impaired hypoglycemia awareness—a condition in which diabetic patients fail to perceive early warning symptoms of low blood glucose, substantially increasing their risk of severe hypoglycemia. Developed by Clarke and colleagues in 1995, it is the most widely used screening tool for this dangerous complication in type 1 diabetes and in insulin-treated type 2 diabetes populations. |
| ScholarGateडेटासेट ↗ |
|
|